Shuimu BioSciences

In the rapidly evolving field of structural biology, cryo-electron microscopy (cryo-EM) has emerged as a transformative technique, capable of revealing the intricate 3D structures of biological macromolecules at near-atomic resolution. A successful cryo-EM project hinges not only on state-of-the-art instrumentation and expert sample preparation but critically on a robust and efficient cryo em pipeline for processing the vast amounts of raw data collected. This pipeline, from initial image acquisition through sophisticated image processing and final model refinement, is what transforms raw microscope outputs into high-quality structural insights.

Shuimu BioSciences, founded in 2017 at Tsinghua University, specializes in providing comprehensive structural determination services, leveraging world-class expertise and advanced platforms. Their services encompass the entire workflow, from upstream protein preparation to the final high-resolution structure, offering a "One-Stop" solution designed to minimize variability and standardize the process.

Understanding the steps within the cryo-EM data pipeline is crucial for appreciating how high-resolution structures are achieved. Let's delve into the typical workflow, highlighting the key stages and how advanced approaches contribute to obtaining exceptional results.

The Cryo-EM SPA Workflow: A Step-by-Step Pipeline

Single Particle Analysis (SPA) is a primary cryo-EM approach used to determine the 3D structures of biological macromolecules like proteins and viruses. The SPA workflow, as outlined by Shuimu BioSciences, involves several critical steps that form the core of the cryo em pipeline. While the overall process begins with project consultation and strategy definition, the technical pipeline commences with sample preparation and data acquisition, leading into rigorous image processing and analysis.

1. Protein Expression & Purification: The quality of the starting material profoundly impacts the final structure resolution. The cryo-EM pipeline begins well before the microscope is even used, starting with the preparation of high-quality, homogeneous samples. Shuimu BioSciences recognizes this critical upstream requirement and offers comprehensive protein expression and purification services. They utilize various systems including E. coli, mammalian cells, insect cells, and cell-free expression to produce target proteins in their optimal state. Purification employs methods like affinity chromatography, ion-exchange chromatography, gel filtration, and RP-HPLC to ensure high purity, typically requiring >90% or even >95% purity for cryo-EM and negative staining, respectively. Sample requirements are specific, emphasizing concentration, volume, buffer composition, and minimizing freeze-thaw cycles. This robust protein preparation stage is the foundational input for the cryo-EM pipeline.

2. Negative Staining (Optional but Recommended Initial Check): Before committing to cryo-EM data collection, negative staining is often employed as a cost-effective method to quickly assess sample particle size, uniformity, morphology, and concentration. This provides low-resolution 2D projection images that help evaluate the sample's suitability for cryo-EM, minimizing the risk and cost associated with full cryo-EM data acquisition if the sample quality is insufficient. Factors like sample concentration, buffer composition (avoiding polysaccharides, DMSO, glycerol), and uniformity assessed via molecular sieving are important for successful negative staining.

3. Sample Freezing & Data Collection: This is where the raw data for the pipeline is generated. Prepared samples are rapidly frozen, typically into vitreous ice, to preserve their native state. Data acquisition is then performed using high-power electron microscopes. Shuimu BioSciences operates a large commercial cryo-EM platform with 300 kV instruments, including G3i, G4, and Totem models, available 24 hours a day. They have 2 such instruments in Beijing and 6 in Hangzhou, enabling significant data acquisition capacity. Daily platform maintenance and experienced technicians ensure that data is collected under optimal conditions, with instruments boasting high annual availability and fault-free operation rates. High-performance detectors, energy filters, spherical aberration correctors, and phase plates are utilized to maximize imaging quality. The raw output consists of extensive 2D projection images of the macromolecular particles.

4. 2D Particle Picking: The first major step in the image processing part of the cryo em pipeline is identifying the individual particle images within the vast number of collected micrographs. This involves computationally picking out the projections of the macromolecule from the background ice and grid. Accurate particle picking is crucial, as including noise or non-particle areas can negatively impact downstream processing. This step relies heavily on computational algorithms. Shuimu BioSciences utilizes independently developed AI algorithms within their SMART software suite to streamline cryo-EM data analysis, including potentially improving particle picking efficiency and accuracy.

5. 3D Reconstruction: Once particles are picked and classified (often through 2D classification, a common intermediate step within image processing), computational algorithms are used to combine the multitude of 2D projections from different orientations into a single 3D map of the macromolecule. This is a computationally intensive step that requires robust algorithms and significant computing resources. The goal is to generate an initial low-resolution 3D model. The quality of this initial model depends heavily on the quality and diversity of the 2D data and the effectiveness of the image processing algorithms.

6. Model Refinement: The initial 3D reconstruction is then refined to improve its resolution and accuracy. This iterative process involves aligning the experimental data to the developing 3D map and refining the map itself. Achieving high resolution, such as the 1.8 Å resolution reported by Shuimu BioSciences, requires meticulous refinement and high-quality input data. This stage is critical for resolving fine structural details necessary for understanding function or guiding drug design. AI-driven platforms like Shuimu's SMART software can potentially enhance the efficiency and accuracy of these complex image processing and refinement steps.

7. Data Delivery: The final step of the pipeline is the delivery of the high-resolution 3D structure and associated data to the client. This includes the electron potential map and potentially atomic models built into the map.

Overcoming Challenges in the Pipeline

The cryo-EM pipeline, particularly the data collection and image processing stages, faces several inherent challenges:

· Small Protein Molecular Weight: Resolving the structure of smaller proteins can be difficult. Shuimu BioSciences has successfully elucidated protein structures as small as 51 kDa, demonstrating expertise in handling different molecular sizes.

· Low Sample Concentration: Obtaining sufficient data from dilute samples is challenging.

· High Background Noise: Distinguishing particles from background noise in micrographs requires sophisticated image processing.

· Air-Water Interface Disruption: The interface between the sample and the air during sample preparation can cause damage or preferential orientation.

· Preferential Orientation: Particles adopting limited orientations in the ice makes 3D reconstruction difficult due to missing views.

Shuimu BioSciences employs several strategies to overcome these hurdles within their cryo em pipeline:

· AI-Driven Platforms: Their proprietary SMART software suite utilizes AI to streamline analysis, potentially improving efficiency and accuracy, and reducing the required data volume. NanoSMART specifically aids in the characterization and identification of nanoparticles like LNPs, liposomes, AAV, and VLPs, enhancing the initial data quality assessment for these complex samples.

· Proprietary Graphene Grids: Shuimu has developed the GraFuture™ series of graphene support grids, including GO and RGO, designed as a potential solution to issues like preferential orientation, low concentration, high background noise, and air-water interface damage. These grids can significantly improve the quality of the raw data collected for the pipeline.

· Extensive Experience: The team's experience with over 400 completed cryo-EM projects and more than 150 resolved structures, covering diverse sample types like membrane proteins, antigen-antibody complexes, etc., provides valuable expertise in optimizing the pipeline for challenging targets.

· Rigorous Sample Preparation: Their "One-Stop" approach, integrating protein expression and purification, ensures that the best possible quality samples enter the pipeline, reducing variability. Strict quality control, including cryo-EM analysis, is applied to samples.

The Outcomes: High-Resolution Structures for Critical Applications

The successful execution of the cryo em pipeline, powered by advanced image processing and expert analysis, yields high-resolution 3D structures that are invaluable for various life science and drug development applications.

· Biomacromolecular Analysis: Resolving the structures of proteins (including challenging membrane proteins like GPCRs and ion channels), DNA/RNA structures, protein-nucleic acid complexes, and viral particles provides fundamental insights into their function. Specific examples include resolving structures of TRPV4, TRPML1, CYP51, ribosomes, transcription complexes, and various viral components.

· Vaccine Development: Cryo-EM aids in viral structure analysis, understanding entry mechanisms, guiding vaccine design, and assessing vaccine quality attributes like morphology and aggregation. It also clarifies antibody-vaccine interactions and helps respond to viral mutations by enabling rapid structural analysis of new variants. The determination of the SARS-CoV-2 spike protein structure in complex with ACE2 is a prime example.

· Antibody Drug Development: High-resolution structures of antibody-antigen complexes reveal interaction mechanisms, guiding optimization for higher affinity and specificity. Cryo-EM helps study antibody drug mechanisms of action and analyze complex targets like membrane proteins. The rapid pace of data acquisition accelerates drug development processes.

· MicroED Solutions: While distinct from SPA, MicroED also involves structure determination from crystalline samples and utilizes electron diffraction. Shuimu's eTasED software integrates this technology into conventional cryo-EM systems, providing high-resolution structures (0.6-1.0 Å achieved) for small molecule drugs, peptides, and protein crystals. This represents another facet of electron microscopy data processing offered.

Shuimu BioSciences has demonstrated its capability through numerous successful cases, resolving atomic-level resolution structures of diverse samples published in top journals. Their library of solved structures includes important drug targets and viral proteins.

Conclusion

The cryo em pipeline, from sample preparation and data acquisition to the complex stages of image processing and model refinement, is a sophisticated process essential for unlocking the high-resolution structural details provided by cryo-EM. Challenges inherent in the technique require advanced solutions and expertise. Shuimu BioSciences addresses these challenges through their integrated One-Stop SPA and protein preparation services, cutting-edge instrumentation, AI-driven software, proprietary grids, and a highly experienced team.

By mastering each stage of the pipeline and continuously pushing the boundaries of resolution, Shuimu BioSciences enables researchers to gain profound insights into the structure and function of biological molecules, accelerating discovery in life sciences, vaccine development, and antibody drug design.

To learn more about Shuimu BioSciences' comprehensive cryo-EM services, including their efficient pipeline, advanced image processing capabilities, and how they can support your research projects, please visit https://shuimubio.com/.

Contact us

See Unseeable.
Drug Undruggable.

Founded in 2017, Shuimu BioSciences aims to bring the power of cryo-EM to innovative therapeutics developers.

Contacts

1 Broadway 5th floor, Cambridge, MA 02142, United States+1 (650) 680 9383

Hi@shuimubio.com

Copyright © 2026 Shuimu Biosciences Ltd.
京ICP备2020035593号